Personal Products company Cupid announced Q1FY27 results Consolidated Financial Highlights: Revenue from operation for Q1FY27 stood at Rs 15,471.50 lakh, compared to Rs 11,996.17 lakh in Q4FY26 (up 28.97% QoQ) and Rs 5,980.49 lakh in Q1FY26 (up 158.70% YoY). Total Income for Q1FY27 reached Rs 15,698.01 lakh, representing a growth of 18.88% QoQ from Rs 13,204.36 lakh and an increase of 142.45% YoY from Rs 6,474.68 lakh. Profit From Ordinary Activities Before Tax for Q1FY27 was Rs 5,991.87 lakh, marking an increase of 26.27% QoQ compared to Rs 4,745.15 lakh and a 206.47% YoY increase from Rs 1,955.14 lakh. Net Profit for Q1FY27 was reported at Rs 4,414.88 lakh, as against Rs 3,626.25 lakh in Q4FY26 (up 21.75% QoQ) and Rs 1,500.74 lakh in Q1FY26 (up 194.18% YoY). Total Comprehensive Income for the period Q1FY27 was Rs 169.26 lakh, down from Rs 3,637.03 lakh in Q4FY26 and Rs 1,500.74 lakh in Q1FY26, primarily due to an Other Comprehensive Loss of Rs (4,245.62) lakh related to equity instruments. Standalone Financial Highlights: Revenue from operation for Q1FY27 was Rs 15,471.50 lakh, showing a QoQ growth of 28.97% from Rs 11,996.17 lakh in Q4FY26 and a YoY growth of 158.70% from Rs 5,980.49 lakh in Q1FY26. Total Income for the quarter stood at Rs 15,698.01 lakh, an increase of 18.88% QoQ and 142.45% YoY. Profit From Ordinary Activities Before Tax for Q1FY27 was Rs 5,993.21 lakh, increasing by 26.30% QoQ and 206.38% YoY. Net Profit for Q1FY27 reached Rs 4,416.21 lakh, reflecting a QoQ increase of 21.78% and a YoY increase of 194.07%. Total Comprehensive Income for Q1FY27 was Rs 170.59 lakh, compared to Rs 3,637.04 lakh in Q4FY26 and Rs 1,501.77 lakh in Q1FY26. Business Highlights: Strategic Investment: The company made a long-term strategic investment in Baazar Style Retail Limited by subscribing to its fully convertible warrants, which are to be converted into equity shares within 18 months from the date of issue. Project Exploration: The Board has given in-principle approval for an exploratory exercise to evaluate a proposed business project in West Bengal. This involves assessing land and infrastructure for the manufacturing, marketing, and distribution of medical devices and healthcare products. Subsidiary Consolidation: The company consolidated several entities acquired during the previous financial year, including Ramson Medical Distributors Private Limited, Sai RK Pharma Private Limited, Well Wisher Pharma Private Limited, Anand Medilink Private Limited, Ace Cardiopathy Solutions Private Limited, Bioaide Technologies Private Limited, and Anand Chemiceutics Private Limited. Post-Quarter Developments: Subsequent to June 30, 2026, R S M Pharma Private Limited (a wholly owned subsidiary) subscribed to 100% equity shares of Qurovia Lifesciences Private Limited on July 25, 2026. Business Agreements: Sai Pharma Distributors Private Limited (a subsidiary) entered into a business transfer agreement with Vishal Surgicals and Vishal Surgicals & Medicals, a transaction expected to be completed by December 31, 2026. Result PDF